Wainamics, Inc.

Campbell, CA Doing business as Wainamics Inc.

UEI
F3ALHDDT12M3
CAGE
78V75
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Asian-Pacific American Owned
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
492 Division St, Campbell, CA 95008, USA
Website
wainamics.com
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Capital Goods
  3. Industrial Conglomerates
  4. Industrials & Manufacturing
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Wainamics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase II - long term cell culture monitoring system Contract · 80NSSC24CA160 Shared Services Center $1,274,527
Sbir phase i long term cell culture monitoring system Contract · 80NSSC23PB625 Shared Services Center $149,942

About Wainamics, Inc.

Wainamics, Inc., doing business as Wainamics Inc., is a minority-owned, woman-owned, and economically disadvantaged small business based in Pleasanton, California. The company specializes in advanced biomedical research and development, with a focus on microfluidics and diagnostic technologies. Registered with the U.S. federal government since October 2014, Wainamics has established itself as a valuable partner for federal agencies, providing innovative solutions in cell culture monitoring systems and CRISPR-based diagnostic tools. The company's expertise spans the development of sophisticated biomedical monitoring systems and novel microfluidic cartridges, contributing to advancements in space exploration, life sciences, and cutting-edge diagnostic technologies.

Wainamics has secured significant federal contract awards through the Small Business Innovation Research (SBIR) program, primarily from the National Aeronautics and Space Administration (NASA). In August 2023, the company was awarded a Phase I SBIR contract worth $149,942 to develop a long-term cell culture monitoring system. Building on this success, Wainamics received a Phase II SBIR contract in June 2024, valued at $899,527, to further advance the long-term cell culture monitoring system. Both contracts were awarded through NASA's Shared Services Center and designated for total small business participation. These awards highlight Wainamics' capability to create sophisticated biomedical monitoring systems that align with NASA's research objectives, potentially contributing to advancements in space exploration and life sciences. The company's work under these contracts demonstrates its expertise in developing innovative technologies for long-term cell culture monitoring, which has applications in both space-based and terrestrial research environments.

In addition to its federal contracts, Wainamics has secured federal grant sub-awards through collaborations with academic institutions, particularly the University of California. These sub-awards focus on the development of novel microfluidic cartridges and diagnostic solutions using CRISPR technology. The scope of work includes optimizing cartridge designs for saliva sample processing, enhancing system performance for optical data collection, and refining on-cartridge assays for improved reproducibility and detection limits. Wainamics' responsibilities encompass a range of tasks, including cartridge optimization for repeatability, system optimization for assay steps and optical data collection, on-cartridge assay optimization for limit of detection studies, coordination of instrument engineering development efforts, and transfer of designs to injection molding for scalability. The company's work on these projects involves collaboration with the Doudna Lab and coordination with entities like Fusion Biotec for instrument development. These grant-funded projects demonstrate Wainamics' critical role in advancing cutting-edge biomedical technologies and its ability to contribute to federally funded research initiatives in partnership with prestigious academic institutions.

Quick answers

What is Wainamics, Inc.'s UEI?

Wainamics, Inc.'s Unique Entity ID (UEI) in SAM.gov is F3ALHDDT12M3.

What is Wainamics, Inc.'s CAGE code?

Wainamics, Inc.'s CAGE code is 78V75.

What is Wainamics, Inc.'s primary NAICS code?

Wainamics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Wainamics, Inc. located?

Wainamics, Inc.'s physical address in SAM.gov is 492 Division St, Campbell, CA 95008, USA.

Is Wainamics, Inc. registered in SAM.gov?

Yes. Wainamics, Inc.'s SAM.gov registration is active through February 9, 2027.

What is Wainamics, Inc.'s most recent federal award?

Wainamics, Inc.'s most recent federal contract award is Sbir phase II - long term cell culture monitoring system (80NSSC24CA160), from Shared Services Center, on June 14, 2024.

On GovTribe

See Wainamics, Inc.'s full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors